Changes in Quality-of-Life and Psychosocial Adjustment among Multiple Myeloma Patients Treated with High-Dose Melphalan and Autologous Stem Cell Transplantation
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
High-dose melphalan and autologous hematopoietic stem cell transplantation (HSCT) is a standard treatment for myeloma, but very little is known about the psychosocial or quality-of-life difficulties that these patients encounter during treatment. Data regarding older patients is particularly scarce. Using a prospective design, this investigation evaluated 94 patients at stem cell collection and again after high-dose therapy and transplantation. Outcomes included quality-of-life (FACT-BMT) and psychosocial adjustment (ie, Brief Symptom Inventory, Impact of Events Scale, and Satisfaction with Life Scale). Findings were compared with age- and sex-adjusted population norms and with transplantation patient norms. At stem cell collection, physical deficits were common, with most patients scoring 1 standard deviation below population norms for physical well-being (70.2%) and functional well-being (57.5%), and many reporting at least moderate fatigue (94.7%) and pain (39.4%). Clinically meaningful levels of anxiety (39.4%), depression (40.4%), and cancer-related distress (37.0%) were evident in a notable proportion of patients. After transplantation, there was a worsening of transplant-related concerns (P < .05), depression (P < .05), and life-satisfaction (P < .001); however, pain improved (P < .01), and social functioning was well preserved. Overall, the declines in functioning after transplantation were less pronounced than anticipated. Older patients were not more compromised than younger ones; in multivariate analyses, they reported better overall quality of life (P < .01) and less depression (P < .05) before transplantation. Our findings emphasize the importance of early screening and intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Attal, M., Harousseau, J.-L., Stoppa, A.-M., Sotto, J.-J., Fuzibet, J.-G., Rossi, J.-F., Casassus, P., Maisonneuve, H., Facon, T., Ifrah, N., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607113350204 · Cited by 2,548
High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma
Child, J. A., Morgan, G. J., Davies, F. E., Owen, R. G., Bell, S. E., Hawkins, K., Brown, J., Drayson, M. T., & Selby, P. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022340 · Cited by 1,768 · cited 1×
“023 has become a front-line treatment for myeloma [1-3].”
Brucker, P. S., Yost, K., Cashy, J., Webster, K., & Cella, D. (2005) · Evaluation & the Health Professions · doi:10.1177/0163278705275341 · Cited by 528 · cited 1×
“Previous research has identified 2 points as the ‘‘minimally important difference’’ (ie, reflecting clinically meaningful change) [23].”
McQuellon, R., Russell, G., Cella, D., Craven, B., Brady, M., Bonomi, A., & Hurd, D. (1997) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1700672 · Cited by 466 · cited 10×
“In addition to healthy population norms, FACT scores were compared with norms from BMT patients [16], using effect sizes and 1-sample t-tests.”
InfluentialAndrykowski, M. A., Bishop, M. M., Hahn, E. A., Cella, D. F., Beaumont, J. L., Brady, M. J., Horowitz, M. M., Sobocinski, K. A., Rizzo, J. D., & Wingard, J. R. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.189 · Cited by 320
Prospective study of religious coping among patients undergoing autologous stem cell transplantation
Sherman, A. C., Plante, T. G., Simonton, S., Latif, U., & Anaissie, E. J. (2009) · Journal of Behavioral Medicine · doi:10.1007/s10865-008-9179-y · Cited by 141
Self-citation
Cited by
Prospective study of religious coping among patients undergoing autologous stem cell transplantation
Sherman, A. C., Plante, T. G., Simonton, S., Latif, U., & Anaissie, E. J. (2009) · Journal of Behavioral Medicine · doi:10.1007/s10865-008-9179-y · Cited by 141
Self-citationBraamse, A. M. J., Gerrits, M. M. J. G., van Meijel, B., Visser, O., van Oppen, P., Boenink, A. D., Cuijpers, P., Huijgens, P. C., Beekman, A. T. F., & Dekker, J. (2012) · Bone Marrow Transplantation · doi:10.1038/bmt.2011.130 · Cited by 101
Spiritual Absence and 1-Year Mortality after Hematopoietic Stem Cell Transplant
Pereira, D. B., Christian, L. M., Patidar, S., Bishop, M. M., Dodd, S. M., Athanason, R., Wingard, J. R., & Reddy, V. S. (2010) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2010.03.003 · Cited by 94
Somers, T. J., Kelleher, S. A., Dorfman, C. S., Shelby, R. A., Fisher, H. M., Rowe Nichols, K., Sullivan, K. M., Chao, N. J., Samsa, G. P., Abernethy, A. P., et al. (2018) · JMIR mHealth and uHealth · doi:10.2196/mhealth.8565 · Cited by 40
Sirilla, J., & Overcash, J. (2013) · Supportive Care in Cancer · doi:10.1007/s00520-012-1637-y · Cited by 31
“Following transplantation, depression, anxiety, and cancerrelated distress tend to worsen from levels at pretransplant [42].”
Metadata
- Authors
- Sherman, A. C., Simonton, S., Latif, U., Plante, T. G., & Anaissie, E. J.
- Venue
- Biology of Blood and Marrow Transplantation
- Publisher
- Elsevier BV
- Published
- 2009-01
- Volume
- 15
- Issue
- 1
- Pages
- 12-20
- ISSN
- 1083-8791 (ISSN-L)
- OpenAlex
- W1989136584
- Cited by
- 110
- References
- 6
- FWCI
- 3.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.